- Home
- NBTX vs SISI Comparison
NBTX vs SISI Comparison
Compare NBTX & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- SISI
- Stock Information
- Founded
- NBTX 2003
- SISI 1997
- Country
- NBTX France
- SISI China
- Employees
- NBTX N/A
- SISI N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- SISI Medicinal Chemicals and Botanical Products
- Sector
- NBTX Health Care
- SISI Health Care
- Exchange
- NBTX Nasdaq
- SISI Nasdaq
- Market Cap
- NBTX 211.9M
- SISI 227.4M
- IPO Year
- NBTX 2020
- SISI 2016
- Fundamental
- Price
- NBTX $9.70
- SISI $6.09
- Analyst Decision
- NBTX Strong Buy
- SISI
- Analyst Count
- NBTX 1
- SISI 0
- Target Price
- NBTX $8.00
- SISI N/A
- AVG Volume (30 Days)
- NBTX 15.1K
- SISI 1.6M
- Earning Date
- NBTX 09-18-2025
- SISI 11-13-2025
- Dividend Yield
- NBTX N/A
- SISI N/A
- EPS Growth
- NBTX N/A
- SISI N/A
- EPS
- NBTX N/A
- SISI N/A
- Revenue
- NBTX N/A
- SISI $9,601,324.00
- Revenue This Year
- NBTX N/A
- SISI N/A
- Revenue Next Year
- NBTX $74.67
- SISI N/A
- P/E Ratio
- NBTX N/A
- SISI N/A
- Revenue Growth
- NBTX N/A
- SISI 1133.26
- 52 Week Low
- NBTX $2.76
- SISI $4.71
- 52 Week High
- NBTX $10.59
- SISI $664.80
- Technical
- Relative Strength Index (RSI)
- NBTX 62.98
- SISI 47.72
- Support Level
- NBTX $8.03
- SISI $5.02
- Resistance Level
- NBTX $9.14
- SISI $6.00
- Average True Range (ATR)
- NBTX 0.56
- SISI 0.57
- MACD
- NBTX -0.02
- SISI 0.22
- Stochastic Oscillator
- NBTX 68.67
- SISI 52.36
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.